Last $17.05 USD
Change Today -0.1395 / -0.81%
Volume 25.8K
SMGZY On Other Exchanges
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

smiths group plc- spon adr (SMGZY) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/28/14 - $24.22
52 Week Low
12/15/14 - $15.69
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SMITHS GROUP PLC- SPON ADR (SMGZY)

Related News

No related news articles were found.

smiths group plc- spon adr (SMGZY) Related Businessweek News

No Related Businessweek News Found

smiths group plc- spon adr (SMGZY) Details

Smiths Group plc develops, manufactures, sells, and supports products and services for the threat and contraband detection, medical devices, energy, communications, and engineered components markets worldwide. The company's John Crane division offers engineered products comprising mechanical seals, seal support systems, engineered bearings, power transmission couplings, and specialist filtration systems for production, transmission and storage, refining, power generation, and petrochemical, as well as pump and compressor manufacturers. Its Smiths Medical division provides medication delivery systems to treat patients with acute and chronic disease and relieve pain; vital care products to reduce hospital-acquired infections, manage patients’ airways, maintain body temperature, and assist reproduction; and safety devices to prevent needlestick injuries and reduce cross-infection to hospitals; homecare, clinics, and other surgery centers; and original equipment manufacturers. The company's Smiths Detection division offers detection technologies, including X-ray, trace detection, and infra-red spectroscopy that detect and identify explosives, weapons, chemical agents, biohazards, nuclear and radioactive material, narcotics, and contraband. Its Smiths Interconnect division provides electronic and radio frequency components and sub-systems that connect, protect, and control critical systems for data centre, wireless telecommunications, aerospace, defense, space, medical, rail, test, and industrial markets. The company's Flex-Tek offers engineered components comprising hosing and rigid tubing, heating elements, and thermal systems that heat and move fluids and gases for the aerospace, medical, industrial, construction, and domestic appliance markets. The company was formerly known as Smiths Industries and changed its name to Smiths Group plc in 2000. Smiths Group plc was founded in 1851 and is headquartered in London, the United Kingdom.

24,100 Employees
Last Reported Date: 09/16/14
Founded in 1851

smiths group plc- spon adr (SMGZY) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 1.5M GBP
Finance Director and Executive Director
Total Annual Compensation: 623.0K GBP
Compensation as of Fiscal Year 2014.

smiths group plc- spon adr (SMGZY) Key Developments

Philip Bowman Intends to Retire as Group Chief Executive of Smiths Group PLC, on December 31, 2015

In order to facilitate the search for his successor, Philip Bowman has given the board of Smiths Group PLC early notification of his intention to retire as Group Chief Executive on 31 December 2015, by which time he will have been in the role for eight years. Philip will continue in his role as Group Chief Executive until his replacement has been appointed and an orderly handover completed.

Smiths Group plc Announces Executive Changes

Smiths Group plc announced the appointment of Zillah Stone as Company Secretary with immediate effect. She has previously held a number of senior corporate legal positions, most recently Group Secretary of BBA Aviation plc. Stone succeeds Sarah Cameron who left the company in August 2014. Mel Rowlands, who stepped in as interim Company Secretary, will resume her duties as company's Deputy General Counsel.

Smiths Group plc Reports Group Earnings Results for the First Quarter Ended November 1, 2014; Reaffirms Earnings Guidance for the Fiscal Year 2015

Smiths Group plc reported group earnings results for the first quarter ended November 1, 2014. For the quarter, the company reported underlying revenue and headline operating profit fell as expected against the first quarter last year as growth in Smiths Medical was more than offset by declines in Smiths Detection and Smiths Interconnect.  At November 1, 2014, net debt was £817 million, slightly increased from the £804 million at July 31, 2014. Expectations for the fiscal year 2015 remain in line with the outlook given at the full year results. Foreign exchange translation and transaction are expected to have an adverse impact of 3% on the Group's first half headline operating profit. However, this headwind is expected to reverse during the second half if current exchange rates are maintained. More generally, as previously guided, the Group's underlying performance will be weighted towards the second half.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SMGZY:US $17.05 USD -0.1395

SMGZY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Babcock International Group PLC 1,004 GBp -8.00
Exelis Inc $17.61 USD -0.28
Flowserve Corp $54.55 USD -1.23
Leidos Holdings Inc $42.44 USD -0.51
Weir Group PLC/The 1,647 GBp +7.00
View Industry Companies

Industry Analysis


Industry Average

Valuation SMGZY Industry Range
Price/Earnings 17.2x
Price/Sales 1.3x
Price/Book 3.2x
Price/Cash Flow 17.1x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITHS GROUP PLC- SPON ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at